Want to see SE:SPAGO full AI Analyst Report?
Spago Nanomedical AB (SPAGO) Income Statement
Spago Nanomedical AB Income Statement
Last quarter (Q2 2026), Spago Nanomedical AB's total revenue was $0.00, a decrease of 100.00% from the same quarter last year. In Q2, Spago Nanomedical AB's net income was $-7.33M. See Spago Nanomedical AB’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 437.00K | $ 1.91M | $ 1.20M | $ 1.05M | $ 660.00K | |
| $ -19.38M | $ -12.36M | $ -23.28M | $ -15.60M | $ -16.78M | |
| $ 11.48M | $ 26.10M | $ 24.49M | $ 25.32M | $ 22.29M | |
| Depreciation and Amortization | $ 167.00K | $ 312.00K | $ 281.00K | $ 356.00K | $ 376.00K |
| $ -26.39M | $ -33.40M | $ -42.22M | $ -38.73M | $ -38.69M | |
| $ -30.86M | $ -33.71M | $ -47.23M | $ -39.47M | $ -39.19M | |
| $ 4.31M | $ 1.20M | $ 850.00K | $ 268.00K | $ 121.00K | |
| $ -26.55M | $ -32.51M | $ -42.22M | $ -39.20M | $ -39.07M | |
| $ -26.55M | $ -32.51M | $ -42.22M | $ -39.31M | $ -39.08M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.07 | $ -0.11 | $ -0.21 | $ -0.29 | $ -0.46 |
| Diluted EPS | $ -0.07 | $ -0.11 | $ -0.21 | $ -0.29 | $ -0.46 |
| Weighted Average Shares Outstanding | 374.81M | 295.42M | 195.96M | 133.62M | 83.66M |
| Weighted Average Shares Outstanding (Diluted) | 374.81M | 295.42M | 195.96M | 190.43M | 83.66M |
Currency in SEK